Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study of the Combination of Indinavir, Ritonavir, Enteric-Coated ddI and d4T In Nucleoside and Non-Nucleoside Reverse Transcriptase Inhibitor Experienced Patients: An Open-Label Study Investigating Differences Between Women and Men

NCT00006397 is registered in ClinicalTrials.gov with PPD Development, LP as lead sponsor.

NCT NCT00006397
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00006397 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study of the Combination of Indinavir, Ritonavir, Enteric-Coated ddI and d4T In Nucleoside and Non-Nucleoside Reverse Transcriptase Inhibitor Experienced Patients: An Open-Label Study Investigating Differences Between Women and Men
Lead sponsor
PPD Development, LP
Phase
Phase 3
Overall status
Unknown status
Start date
August 31, 2000
Completion date
Not reported
Enrollment
200
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infections